Financial Times reporter Clive Cookson writes that MIT researchers have found evidence that flashing lights could potentially be used as a noninvasive treatment for Alzheimer’s disease. The researchers found that “lights flashing on and off 40 times per second restored ‘gamma oscillation’ waves that were suppressed in the disease.”
MIT researchers have found that flashing light may reduce the buildup of beta amyloid protein in the brain, which is associated with Alzheimer’s disease, writes Michelle Roberts for the BBC News. The researchers hope that “clearing beta amyloid and stopping more plaques from forming could halt Alzheimer's and its symptoms.”
Writing for The Atlantic, Ed Yong spotlights a study by MIT researchers that identifies a potential new treatment for Alzheimer’s – using pulses of light to stimulate brain waves. Yong writes that the study “heralds a completely new approach to dealing with Alzheimer’s—changing neural activity, rather than delivering drugs or chemicals.”
MIT researchers have found that exposure to flickering lights at a precise frequency may help fight off Alzheimer’s disease, reports Melissa Healy for The Los Angeles Times. The technique recruits “neurons and other cell types in the brain to sort of enable the brain’s inner ability to repair itself,” explains Prof. Li-Huei Tsai, director of the Picower Institute.
Guardian reporter Hannah Devlin writes about a new study by MIT researchers that shows that strobe lighting can reduce levels of toxic proteins found in Alzheimer’s disease. The researchers found that “exposure to flickering light stimulated brain waves, called gamma oscillations, that are known to be disturbed in Alzheimer’s patients.”
STAT reporter Meghana Keshavan speaks with Prof. Guoping Feng about his new research that shows glial cells “very actively participate in direct neuronal function — particularly in the brain areas that control appetite, energy and metabolism.” The findings could help spur the development of weight loss medications.
MIT researchers have identified a region of the brain responsible for forming habits, reports Anil Ananthaswamy for New Scientist. The researchers found that when performing an action, the prefrontal cortex, communicates with the striatum. “Over time, input from the prefrontal circuits fades, to be replaced by loops linking the striatum to the sensorimotor cortex,” Ananthaswamy explains.
MIT neuroscientists have identified two regions of the brain involved in creating panoramic memories, writes Tara Pattilachan for The Huffington Post. “Our understanding of our environment is largely shaped by our memory for what’s currently out of sight,” says postdoc Caroline Robertson of the importance of understanding how our brains develop panoramic memories.
Inside Higher Ed reporter Colleen Flaherty writes that researchers from MIT and around the world are publicly defending the late Prof. Suzanne Corkin’s work with patient H.M. in response to a highly critical publication. When “so many scholars rise to defend the reputation of a deceased colleague,” says Arthur Caplan, head of NYU’s Division of Bioethics, “that speaks volumes both about her and the problems that exist in the book.”
MIT researchers have discovered that a bacterium found in the human mouth can be used to form a new CRISPR gene-editing system that can target RNA, reports Carl Zimmer for The New York Times. The development “may open up a new front in gene engineering, gaining the ability to precisely adjust the proteins in cells, for instance, or to target cancer cells."
New Scientist reporter Colin Barras writes that MIT researchers have found they can program C2c2, an enzyme found in bacteria, to serve as an RNA-editing tool. Barras writes that the tool “promises to transform our understanding of RNA’s role in our growth and development, and provide a new avenue for treating infectious diseases and cancer.”
Prof. Feng Zhang has been named a recipient of the 2016 Canada Gairdner International Award for his work on the development of the CRISPR gene-editing system, reports CBC News. CRISPR "may prove to be a ‘powerful therapeutic’ for treating human diseases by editing out harmful genetic mutations.”
Globe and Mail reporter Ivan Semeniuk spotlights Prof. Feng Zhang and his role in developing the CRISPR-Cas9 gene-editing system, for which he was honored as a recipient of the 2016 Canada Gairdner International award. “CRISPR genome editing technology is a really powerful platform,” says Zhang. “It think it will advance both our ability to understand disease and to develop treatments.”
MIT researchers have found a possible link between attention deficit disorders and autism, reports Lindsay Kalter for The Boston Herald. “One of the long-term goals is gene therapy where we can actually introduce genetic material that might be missing from the human,” explains grad. student Michael Wells.
Popular Science reporter Claire Maldarelli writes that researchers from MIT have identified how sensory overload occurs for people with neurodevelopmental disorders. Based off their findings, the researchers hope they can "classify these disorders in a better way, but also develop therapies that alleviate or diminish the symptoms.”